- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Measuring Performance of Patient-Centered Outcomes Research
In 2017, the review of the Patient-Centered Outcomes Research Trust Fund will determine the adequacy and the use of funding and there are 3 ways to measure performance in patient-centered outcomes research.
In 2017, the review of the Patient-Centered Outcomes Research Trust Fund will determine the adequacy and the use of funding to determine whether levels should be adjusted in autumn 2019. And now researchers are analyzing work in patient-centered outcomes research to ascertain how well the work is being done and what might be done better, according to a new commentary from RAND.
The Patient-Centered Outcomes Research Institute, established in 2010, has funded hundreds of studies and Thomas W. Concannon, senior policy researcher at RAND, highlights 3 ways to measure performance in patient-centered outcomes research:
- Ongoing and public inventory to explain how trust fund dollars earmarked for patient-centered outcomes research have been spent
- Procedural assessments to examine whether investigators are getting the principles of patient centeredness right
- Evaluation of whether patient-centered outcomes research is making a difference to healthcare quality and outcomes
Read the full commentary at RAND.
Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations
January 7th 2025Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Decisions and Precision in Value-Based Cancer Care
January 7th 2025An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.
Read More
